Article

New Products & Services

FDA OKs treatment for men with testosterone deficiency. Livingston, NJ-The FDA has approved Columbia Laboratories' testosterone buccal system (Striant mucoadhesive) for testosterone replacement therapy. The transbuccal treatment is for men with conditions associated with a deficiency or absence of endogenous testosterone, including hypogonadism.

Related Videos
Raveen Syan, MD, FPMRS, answers a question during a Zoom video interview
Phillip M. Pierorazio, MD, answers a question during a video interview
Phillip M. Pierorazio, MD, answers a question during a video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.